Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Fund Letter | John W. Rogers, Jr.Ariel Fund | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Long BIO (Bio-Rad Laboratories, Inc.) Global leader in laboratory equipment and biological testing, Bio-Rad Laboratories Inc. (BIO) also contributed to performance during the quarter, following better-than-expected results and the reaffirmation of its full-year outlook. Organic revenue exceeded... | BULL | View Pitch → | |
| Oct 15, 2026 | Fund Letter | John W. RogersAriel Appreciation Fund | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Long BIO (Bio-Rad Laboratories, Inc.) Global leader in laboratory equipment and biological testing, Bio-Rad Laboratories Inc. (BIO) also contributed to performance during the quarter, following better-than-expected results and the reaffirmation of its full-year outlook. Organic revenue exceeded... | BULL | View Pitch → | |
| Oct 13, 2026 | Fund Letter | Joe BauernfreundAVI Global Trust | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Long BIO (Bio-Rad Laboratories, Inc.) Earlier in 2026 we established a position in Bio-Rad Labs (“Bio-Rad”). The company exhibits... | BULL | View Pitch → | |
| Aug 21, 2026 | Fund Letter | Ariel Investments, LLCAriel Focus Fund | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Long BIO (Bio-Rad Laboratories Inc.) Additionally, we repurchased Bio-Rad Laboratories Inc. (BIO), a global leader in laboratory equipment and biological testing. Bio-Rad benefits from... | BULL | View Pitch → | |
| Aug 21, 2026 | Fund Letter | James FellowsFirst Eagle Investments | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Long BIO (Bio-Rad Laboratories) Healthcare has been out of favor in recent years, weighed down by post-Covid headwinds, but we find the highly regulated sector to be structurally attractive given growing demand and significant barriers to entry. With a market... | BULL | View Pitch → | |
| Aug 21, 2026 | Fund Letter | Ariel Investments, LLCAriel Small Cap Value Strategy | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Long BIO (Bio-Rad Laboratories Inc.) Also in the quarter, we initiated a new position in manufacturer and developer of laboratory equipment and biological testing, Bio-Rad Laboratories Inc. (BIO). The company offers... | BULL | View Pitch → | |
| Jan 24, 2026 | Fund Letter | Chad MeadeMeridian Small Cap Growth Fund | Zenas BioPharma, Inc. $ZBIO• NASDAQ | BiotechnologyBiotechnology | Meridian Small Cap Growth Fund 2025 Q4 (ZBIO) Zenas BioPharma, Inc. is developing transformative therapies for patients with autoimmune diseases. Its lead drug,... | BULL | View Pitch → |
| Jan 23, 2026 | Fund Letter | Haruki Toyama, Andy Romanowich, Rich EisingerMadison Mid Cap Fund | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Madison Mid Cap Fund 2025 Q4 (BIO) Bio-Techne is a leader in the life sciences research market with a broad portfolio of products that are used to enable discoveries of new drugs, therapeutics, and diagnostics. Around 80% of... | BULL | View Pitch → | |
| Jan 20, 2026 | Fund Letter | Ross GlotzbachLongleaf Partners Global Fund | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Longleaf Partners Global Fund 2025 Q4 (BIO) Bio-Rad – Life-sciences companies Bio-Rad and Avantor combined to detract from our performance this year. We entered the... | BULL | View Pitch → | |
| Jan 15, 2026 | Fund Letter | James FellowsFirst Eagle Investments | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | First Eagle Investments 2025 Q4 (BIO) Healthcare has been out of favor in recent years, weighed down by post-Covid headwinds, but we find the highly regulated sector to be structurally attractive given growing demand and significant barriers to entry. With a market... | BULL | View Pitch → | |
| Nov 28, 2025 | Fund Letter | Chad MeadeMeridian Small Cap Growth Fund | Zenas BioPharma, Inc. $ZBIO• NASDAQ | BiotechnologyBiotechnology | Long ZBIO (Zenas BioPharma, Inc.) Zenas BioPharma advanced its Phase 3 trials for Obexelimab and secured up to $300 million in non-dilutive financing from Royalty Pharma to fund commercialization. The fund trimmed... | BULL | View Pitch → |
| Nov 28, 2025 | Fund Letter | Southeastern Asset Management, Inc.Longleaf Partners Fund | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Longleaf Partners Fund 2025 Q3 (BIO) Bio-Rad Laboratories, a healthcare products manufacturer, was a positive contributor after the company reported steadier earnings than the market expected in a difficult environment. This sets the... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.